Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
Osteogenic potential o
Epigenetic mechanisms
Influenza A Virus, H7N
Structural basis for a
The endocannabinoid no
See All (14) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. J Pharmacol Exp Ther. 2005 Aug; 314(2):868-75.
View in:
PubMed
subject areas
Analgesics
Animals
Arachidonic Acids
Binding, Competitive
Biotransformation
CHO Cells
Cricetinae
Cyclic AMP
Cyclohexanols
Down-Regulation
Endocannabinoids
Enzyme Inhibitors
Glycerides
GTP-Binding Proteins
Guanosine 5'-O-(3-Thiotriphosphate)
HL-60 Cells
Humans
Rats
Rats, Sprague-Dawley
Receptor, Cannabinoid, CB1
Receptor, Cannabinoid, CB2
Receptors, G-Protein-Coupled
Transfection
authors with profiles
Paul Prather